Jacobson Pharma Revamps Executive Pay Process

Jacobson Pharma Corporation Limited (HK:2633) has released an update.

Jacobson Pharma Corporation Limited has revised its Remuneration Committee’s terms to establish a more formal and transparent process for setting executive and senior management pay. Comprising largely of independent non-executive directors, the committee meets annually or as needed to evaluate remuneration policies and report findings to the board, ensuring compliance with Hong Kong Stock Exchange regulations.

For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.